Fisher & Paykel Healthcare Corporation Limited
FSPKF
$20.56
-$1.00-4.64%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.93% | 12.20% | 5.58% | 11.37% | 19.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.93% | 12.20% | 5.58% | 11.37% | 19.61% |
| Cost of Revenue | 7.72% | 8.95% | -5.67% | -0.49% | 15.35% |
| Gross Profit | 12.91% | 14.20% | 13.25% | 19.46% | 22.39% |
| SG&A Expenses | 6.24% | 7.45% | -0.92% | 4.52% | 11.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.10% | 7.31% | -2.30% | 3.06% | 13.79% |
| Operating Income | 27.16% | 28.61% | 34.54% | 41.93% | 44.44% |
| Income Before Tax | 33.29% | 34.81% | 189.34% | 205.22% | 48.35% |
| Income Tax Expenses | 29.01% | 30.48% | -3.20% | 2.11% | 61.45% |
| Earnings from Continuing Operations | 34.78% | 36.32% | 720.56% | 765.59% | 44.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.78% | 36.32% | 720.56% | 765.59% | 44.29% |
| EBIT | 27.16% | 28.61% | 34.54% | 41.93% | 44.44% |
| EBITDA | 23.03% | 24.43% | 30.44% | 37.60% | 40.43% |
| EPS Basic | 34.33% | 35.98% | 715.79% | 761.07% | 43.29% |
| Normalized Basic EPS | 32.94% | 34.48% | 41.80% | 49.60% | 47.16% |
| EPS Diluted | 34.21% | 35.71% | 726.92% | 774.22% | 42.73% |
| Normalized Diluted EPS | 32.88% | 34.44% | 41.65% | 49.52% | 47.03% |
| Average Basic Shares Outstanding | 0.28% | 0.28% | 0.47% | 0.47% | 0.75% |
| Average Diluted Shares Outstanding | 0.31% | 0.31% | 0.54% | 0.54% | 0.83% |
| Dividend Per Share | -0.53% | 0.71% | -5.42% | -0.14% | 4.04% |
| Payout Ratio | 0.16% | 0.16% | -0.79% | -0.79% | -0.25% |